tetranor-PGJM manufacturers
- tetranor-PGJM
-
- $1890.00
-
2026-05-11
- CAS:1352751-83-7
- Purity:
- Supply Ability: 10g
|
| | tetranor-PGJM Basic information |
| Product Name: | tetranor-PGJM | | Synonyms: | tetranor-PGJM;KPFBKANRLYZJQP-DGCLKSJQSA-N;tetranor-PGJM Exclusive;tetranor-prostaglandin J metabolite;3-Cyclopentene-1-octanoic acid, 2-(2-carboxyethyl)-ε,5-dioxo-, (1R,2S)- | | CAS: | 1352751-83-7 | | MF: | C16H22O6 | | MW: | 310.34 | | EINECS: | | | Product Categories: | | | Mol File: | 1352751-83-7.mol |  |
| | tetranor-PGJM Chemical Properties |
| Boiling point | 586.6±35.0 °C(Predicted) | | density | 1.214±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMF: 30 mg/ml; DMSO: 20 mg/ml; Ethanol: 30 mg/ml; PBS (pH 7.2): 1 mg/ml | | pka | 4.59±0.10(Predicted) |
| | tetranor-PGJM Usage And Synthesis |
| Description | Prostaglandin D2 (PGD2) plays a pharmacological role in allergic and asthmatic anaphylaxis, normal physiological sleep and lowering of body temperature, as well as inhibits platelet aggregation and relaxes vascular smooth muscle.1 tetranor-PGDM is an abundant urinary metabolite of PGD2 that is detectable both in human and mouse and, as such, is used as a biomarker of PGD2 biosynthesis.2 tetranor-PGJM is a potential PGD2 metabolite, formed by the elimination of the C-9 hydroxyl group. This compound may serve as a useful control in the analysis of PGD2 biosynthesis.WARNING This product is not for human or veterinary use. | | Definition | ChEBI: Tetranor-PGJM is an oxo carboxylic acid. |
| | tetranor-PGJM Preparation Products And Raw materials |
|